Regeneron Pharmaceuticals Inc.

In News

Investor Notice: Robbins LLP Informs Investors of the Regeneron Pharmaceuticals, Inc. Class Action Lawsuit - Business Wire

Business Wire - Jul 16, 2026

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Regeneron Pharmaceuticals, Inc. Common Stock and Sets a Lead Plaintiff Deadline of September 14, 2026 - GlobeNewswire

GlobeNewswire - Jul 16, 2026

Regeneron Investor Sues Over Cancer Drug Trial Miss, Stock Drops - Bloomberg Law News

Bloomberg Law News - Jul 16, 2026

Disappointing Trial Results Hurt Regeneron Pharmaceuticals (REGN) in Q2 - Yahoo Finance

Yahoo Finance - Jul 13, 2026

Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day - MarketWatch

MarketWatch - Jul 14, 2026

Regeneron and Telix Announce Strategic Radiopharma Collaboration - Regeneron

Regeneron - Apr 13, 2026

Regeneron Pharmaceuticals (REGN) Stumbled In A Trial Setback, Is The Stock Still Cheap? - simplywall.st

simplywall.st - Jul 15, 2026

Regeneron Pharmaceuticals (REGN) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr

Quartr - Jul 14, 2026

Regeneron's Gene Therapy For Genetic Hearing Loss Gets Accelerated FDA Nod — Drug Pricing Deal With White House To Be Announced Today - Stocktwits

Stocktwits - Jul 13, 2026

Cantor Fitzgerald reiterates Overweight on Regeneron stock - Investing.com

Investing.com - Jul 13, 2026

Regeneron drops after skin cancer treatment fails late-stage trial - Reuters

Reuters - May 18, 2026

Is Regeneron Pharmaceuticals, Inc. (REGN) Stock Still a Biotech Leader After Analyst Price Target Cut? - Yahoo Finance

Yahoo Finance - Jul 08, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment